<DOC>
	<DOCNO>NCT00681395</DOCNO>
	<brief_summary>To evaluate safety compare pharmacokinetic parameter fix dose combination ABT-143 relative co-administration two monotherapies .</brief_summary>
	<brief_title>Study Compare Bioavailability ABT-335 Rosuvastatin From ABT-143 Relative That From Co-administration ABT-335 Rosuvastatin Calcium</brief_title>
	<detailed_description />
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>General good health BMI 19 29 Currently enrol another study Females pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>